|本期目录/Table of Contents|

[1]刘元媛,曹晓沧.不同生物活性材料对间充质干细胞功能影响的比较[J].天津医科大学学报,2018,24(05):409-414.
 LIU Yuan-yuan,CAO Xiao-cang.Comparison of the effects of different bioactive materials on mesenchymal stem cells[J].Journal of Tianjin Medical University,2018,24(05):409-414.
点击复制

不同生物活性材料对间充质干细胞功能影响的比较(PDF)
分享到:

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
24卷
期数:
2018年05期
页码:
409-414
栏目:
基础医学
出版日期:
2018-09-20

文章信息/Info

Title:
Comparison of the effects of different bioactive materials on mesenchymal stem cells
作者:
刘元媛曹晓沧
天津医科大学总医院消化内科,天津300052
Author(s):
LIU Yuan-yuan CAO Xiao-cang
Department of Hepato-Gastroenterology, General Hospital, Tianjin Medical University, Tianjin 300052, China
关键词:
水凝胶人胎盘来源的间充质干细胞(hP-MSCs)调节增殖凋亡
Keywords:
hydrogel human placenta-derived mesenchymal stem cells (hP-MSC) regulation proliferationapoptosis
分类号:
R34
DOI:
-
文献标志码:
A
摘要:
目的:研究壳聚糖(CS)及壳聚糖负载的一氧化氮(NO)、胰岛素样生长因子-1C(IGF-1C)与人胎盘来源的间充质干细胞(hP-MSCs)共培养后对细胞功能的影响。方法:利用可稳定表达绿色荧光蛋白(GFP)和萤火虫荧光蛋白(Fluc)的hP-MSCs与3种不同的生物活性材料水凝胶共培养,通过MTT、生物发光成像技术以检测水凝胶对细胞增殖的影响,同时利用real time PCR检测水凝胶对细胞增殖、凋亡、抗炎及血管新生相关细胞因子的表达作用。结果:CS-IGF-1C水凝胶可明显促进hP-MSCs的增殖及上调相关基因IGF-1(11.51)、HGF(6.64)、EGF(9.78)的表达(P< 0.05),抑制hP-MSCs的凋亡并下调相关基因BAX/BAD(1.22/1.12)、FAS/FASLG(1.31/1.70)的表达(P< 0.05),同时还可显著上调hP-MSCs对TSG-6(11.61)及PGE2(16.04)的表达(P< 0.05)。而CS-NO可显著促进hP-MSCs对VEGF(13.28)、PDGF(8.49)的表达作用(P< 0.05)。结论:不同水凝胶对MSCs的影响不同,CS-IGF-1C水凝胶与MSCs共移植可用于治疗组织损伤及炎症性疾病,而CS-NO水凝胶与MSCs共移植可治疗缺血性疾病,为临床及实验室研究提供参考。
Abstract:
Objective: To investigate the effect of chitosan (CS) and chitosan-supported nitric oxide (NO) and insulin-like growth factor-1C (IGF-1C) on placenta-derived mesenchymal stem cells (hP-MSCs) by co-culturing. Methods: HP-MSCs which had stable expression of green fluorescent protein (GFP) and fireflies fluorescent protein (Fluc) were co-cultured with three different bioactive material hydrogels, and the proliferation of hP-MSCs was detected through MTT assay and bioluminescence imaging. Real time PCR was used to detect the relative gene expression of proliferation and apoptosis. Results: In the condition of co-culture with hP-MSCsGFP-Fluc, CS-IGF-1C hydrogel significantly promoted the expression of IGF-1(11.51), HGF (6.64), EGF (9.78) and inhibited the expression of apoptosis-related genes BAX/BAD (1.22/1.12) and FAS/FASLG(1.31/1.70)(P<0.05). At the same time, it significantly promoted the expression of TSG-6(11.61) and PGE2(16.04) by hP-MSCs(P< 0.05). On the other hand, CS-NO significantly promoted the expression of VEGF(13.28) and PDGF(8.49) from hP-MSCs(P<0.05). Conclusion:Different hydrogels have different effect on MSCs. Therefore, CS-IGF-1C hydrogel co-transplantated with MSCs would be used in the treatment of tissue damage and inflammatory diseases, and CS-NO hydrogel co-transplantated with MSCs may also be used in the treatment of tissue ischemic disease.

参考文献/References:


[1] Bianco P, Sacchetti B, Riminucci M. Osteoprogenitors and the hematopoietic microenvironment[J]. Best Pract Res Clin Haematol,2011,24(1): 37
[2] Phinney D G, Kopen G, Isaacson R L, et al. Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: variations in yield, growth, and differentiation[J]. J Cell Biochem,1999,72(4): 570
[3] Caplan A I, Dennis J E. Mesenchymal stem cells as trophic mediators[J]. J Cell Biochem, 2006,98(5): 1076
[4] Levi B, Longaker M T. Concise review: adipose-derived stromal cells for skeletal regenerative medicine[J]. Stem Cells, 2011,29(4): 576
[5] Wexler S A, Donaldson C, Denning-Kendall P, et al. Adult bone marrow is a rich source of human mesenchymal ‘stem’ cells but umbilical cord and mobilized adult blood are not[J]. Br J Haematol,2003,121(2): 368
[6] Grisendi G, Bussolari R, Cafarelli L, et al. Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy[J]. Cancer Res, 2010,70(9): 3718
[7] Lu L L, Liu Y J, Yang S G, et al. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials[J]. Haematologica, 2006, 91(8): 1017
[8] Irvine E J. Usual therapy improves perianal Crohn’s disease as measured by a new disease activity index. McMaster IBD Study Group[J]. J Clin Gastroenterol,1995,20(1): 27
[9] Li C D, Zhang W Y, Li H L, et al. Mesenchymal stem cells derived from human placenta suppress allogeneic umbilical cord blood lymphocyte proliferation[J]. Cell Res, 2005,15(7): 539
[10] Kim P J, Mahmoudi M, Ge X, et al. Direct evaluation of myocardial viability and stem cell engraftment demonstrates salvage of the injured myocardium[J]. Circ Res,2015,116(7): e40
[11] He S, Gleason J, Fik-Rymarkiewicz E,et al. Human placenta-derived mesenchymalstromal-like cells enhance angiogenesis via T cell-dependent reprogramming of macrophage differentiation[J]. Stem Cells, 2017,35(6): 1603
[12] Solis M A, Wei Y H, Chang C H, et al. Hyaluronan upregulates mitochondrial biogenesis and reduces adenoside triphosphate production for efficient mitochondrial function in slow-proliferating human mesenchymal stem cells[J]. Stem Cells, 2016,34(10): 2512
[13] In 'T Anker P S, Scherjon S A, Kleijburg-Van Der Keur C,et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta[J]. Stem Cells, 2004,22(7): 1338
[14] Lankford L, Chen Y J, Saenz Z, et al. Manufacture and preparation of human placenta-derived mesenchymal stromal cells for local tissue delivery[J]. Cytotherapy,2017,19(6): 680
[15] Song W J, Li Q, Ryu M O, et al. TSG-6 Secreted by human adipose tissue-derived mesenchymalstem cells ameliorates DSS-induced colitis by inducing M2 macrophage polarization in Mice[J]. Sci Rep,2017,7(1): 5187
[16] Sala E, Genua M, Petti L, et al. Mesenchymal stem cells reduce colitis in mice via release of TSG6,independently of their localization to the intestine[J]. Gastroenterology, 2015,149(1): 163
[17] Nemeth K, Leelahavanichkul A, Yuen P S, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production[J]. Nat Med,2009,15(1): 42
[18] Du W, Zhang K, Zhang S, et al. Enhanced proangiogenic potential of mesenchymal stem cell-derived exosomes stimulated by a nitric oxide releasing polymer[J]. Biomaterials, 2017,133: 70
[19] Feng G, Zhang J, Li Y, et al. IGF-1 C domain-modified hydrogel enhances cell therapy for AKI[J]. J Am Soc Nephrol, 2016,27(8): 2357
[20] Yang W, Zheng H, Wang Y, et al. Nesprin-1 has key roles in the process of mesenchymal stem cell differentiation into cardiomyocyte-like cells in vivo and in vitro[J]. Mol Med Rep, 2015,11(1): 133
[21] Ulrich H, Do Nascimento I C, Bocsi J, et al. Immunomodulation in stem cell differentiation into neurons and brain repair[J]. Stem Cell Rev, 2015, 11(3): 474
[22] Li X, Bai J, Ji X, et al. Comprehensive characterization of four different populations of human mesenchymal stem cells as regards their immune properties,proliferation and differentiation[J]. Int J Mol Med, 2014, 34(3): 695
[23] Zhang T, Lee Y W, Rui Y F, et al. Bone marrow-derived mesenchymal stem cells promote growth and angiogenesis of breast and prostate tumors[J]. Stem Cell Res Ther, 2013, 4(3): 70
[24] Baustian C, Hanley S, Ceredig R. Isolation,selection and culture methods to enhance clonogenicity of mouse bone marrow derived mesenchymal stromal cell precursors[J]. Stem Cell Res Ther, 2015, 6: 151
[25] Li J, Chen Y, Chen Z, et al. Therapeutic effects of human adipose tissue-derived stem cell (hADSC) transplantation on experimental autoimmune encephalomyelitis (EAE) mice[J]. Sci Rep, 2017, 7: 42695
[26] Lee J M, Jung J, Lee H J, et al. Comparison of immunomodulatory effects of placenta mesenchymal stem cells with bone marrow and adipose mesenchymal stem cells[J]. Int Immunopharmacol, 2012, 13(2): 219
[27] Antoniadou E, David A L. Placental stem cells[J]. Best Pract Res Clin Obstet Gynaecol, 2016,31: 13
[28] Weissleder R. Molecular imaging: exploring the next frontier[J]. Radiology, 1999, 212(3): 609
[29] Wang R, Zhang K, Tao H, et al. Molecular imaging of tumor angiogenesis and therapeutic effects with dual bioluminescence[J]. Curr Pharm Biotechnol, 2017, 18(5): 422
[30] Leng L, Wang Y, He N, et al. Molecular imaging for assessment of mesenchymal stem cells mediated breast cancer therapy[J]. Biomaterials, 2014,35(19): 5162
[31] Iochmann S, Lerondel S, Blechet C, et al. Monitoring of tumour progression using bioluminescence imaging and computed tomography scanning in a nude mouse orthotopic model of human small cell lung cancer[J]. Lung Cancer, 2012,77(1): 70
[32] Tiernan A R, Sambanis A. Bioluminescence tracking of alginate micro-encapsulated cell transplants[J]. J Tissue Eng Regen Med, 2017, 11(2): 501
[33] Huang C C, Wei H J, Lin K J, et al. Multimodality noninvasive imaging for assessing therapeutic effects of exogenously transplanted cell aggregates capable of angiogenesis on acute myocardial infarction[J]. Biomaterials, 2015,73: 12
[34] Robinson S T, Douglas A M, Chadid T, et al. A novel platelet lysate hydrogel for endothelial cell and mesenchymal stem cell-directed neovascularization[J]. Acta Biomater, 2016,36: 86
[35] Wang X, Zhang J, Cui W, et al. Composite hydrogel modified by IGF-1C domain improves stem cell therapy for limb ischemia[J].ACS Appl Mater Interfaces,2018,10(5): 4481

相似文献/References:

备注/Memo

备注/Memo:
作者简介 刘元媛(1990-),女,硕士在读,研究方向:炎症性肠病与干细胞治疗;通信作者:曹晓沧,E-mali:docxccao@163.com。
更新日期/Last Update: 2018-09-30